Scott Zamvil, MD, PhD

Title(s)Professor, Neurology
SchoolSchool of Medicine
Address675 Nelson Rising Lane, #215A
San Francisco CA 94158
Phone415-502-7395
ORCID ORCID Icon0000-0003-2720-9915 Additional info
vCardDownload vCard
    Other Positions
    Title(s)UCSF Weill Institute for Neurosciences


    Collapse Biography 
    Collapse Education and Training
    Stanford UniversityM.D.1988School of Medicine

    Collapse Overview 
    Collapse Overview
    Dr. Scott Zamvil is a neurologist and immunologist who specializes in treating multiple sclerosis and neuromyelitis optica. His research focuses on developing novel treatments for these autoimmune diseases.

    Zamvil earned his medical degree and a doctorate in microbiology and immunology from Stanford University. He then completed a residency in internal medicine at Stanford University and a residency in neurology at Brigham and Women's Hospital. Before coming to UCSF, he was a neurologist at Brigham and Women's Hospital.

    Zamvil is a board member of the International Society of Neuroimmunology. He is also an adviser for America's Committee for Treatment and Research in Multiple Sclerosis. He serves as deputy editor of the journal Neurology: Neuroimmunology & Neuroinflammation.

    Collapse Research 
    Collapse Research Activities and Funding
    Single cell RNA-Seq and clonal analysis of CD8+ T cells in MS
    NIH R21AI142186Jul 1, 2019 - Jun 30, 2021
    Role: Principal Investigator
    Repertoire selection of AQP4-specific T cells that cause CNS autoimmunedisease
    NIH R01AI131624Dec 24, 2018 - Nov 30, 2023
    Role: Principal Investigator
    Influence of NMO gut microbiota on CNS autoantigen-specific T cell responses
    NIH R21NS108159Sep 1, 2018 - Aug 31, 2020
    Role: Principal Investigator
    Regulatory monocytes in CNS autoimmune disease
    NIH R01NS063008Jul 1, 2009 - Jun 30, 2014
    Role: Principal Investigator
    B cells in CNS autoimmunity
    NIH R01AI073737Jan 1, 2009 - Dec 31, 2013
    Role: Principal Investigator
    Immunomodulation of inflammatory disease by atorvastatin
    NIH R01AI059709Jan 15, 2005 - Dec 31, 2010
    Role: Principal Investigator
    MHC class II regulation and antigen processing in EAE
    NIH R01NS046721Feb 1, 2004 - Nov 30, 2008
    Role: Principal Investigator
    MHC CLASS II TRANSACTIVATOR (CIITA) IN CNS AUTOIMMUNITY
    NIH K02NS002207Jan 1, 2001 - Dec 31, 2005
    Role: Principal Investigator
    B7 COSTIMULATION AND CNS INFLAMMATORY DISEASE
    NIH K08NS001771Sep 30, 1994 - Dec 31, 2000
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Progressive Encephalomyelopathy in an Older Man: A Case Report From the National Multiple Sclerosis Society Case Conference Proceedings. Neurol Neuroimmunol Neuroinflamm. 2024 May; 11(3):e200210. Ross LA, Lee J, Carlson AK, Conway DS, Cohen JA, Graves J, Zamvil SS, Newsome SD, Kunchok A. PMID: 38386951.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    2. A 42-Year-Old Woman With Rapidly Expanding White Matter Lesions: From the National Multiple Sclerosis Society Case Conference Proceedings. Neurol Neuroimmunol Neuroinflamm. 2024 May; 11(3):e200201. Amiola TO, Oh U, Richard H, Newsome SD, Graves J, Zamvil SS, Goldman MD. PMID: 38285968.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    3. Relapsing White Matter Disease and Subclinical Optic Neuropathy: From the National Multiple Sclerosis Society Case Conference Proceedings Neurol Neuroimmunol Neuroinflamm. 2024 03; 11(2):e200194. O'Neill KA, Dugue A, Abreu NJ, Balcer LJ, Branche M, Galetta S, Graves J, Kister I, Magro C, Miller C, Newsome SD, Pappas J, Rucker J, Steigerwald C, William CM, Zamvil SS, Grossman SN, Krupp LB. PMID: 38181317.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    4. Teenager With Recurrent Ataxia, Ophthalmoplegia, and Encephalopathy Associated With Demyelination: From the National Multiple Sclerosis Society Case Conference Proceedings Neurol Neuroimmunol Neuroinflamm. 2024 03; 11(2):e200193. Poisson KE, Newsome SD, Graves J, Zamvil SS, Marcus LR. PMID: 38181318.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    5. Tuberculous Meningitis or Neurosarcoidosis-a Diagnostic Quandary. From the National Multiple Sclerosis Society Case Conference Proceedings Neurol Neuroimmunol Neuroinflamm. 2024 01; 11(1):e200184. Lin J, Pulst-Korenberg J, Zamvil SS, Graves J, Newsome SD, Amezcua L. PMID: 38118077; PMCID: PMC10732344.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    6. Targeting PGLYRP1 in cancer and autoimmunity. Nat Immunol. 2023 Nov; 24(11):1785-1786. Moseley CE, Zamvil SS. PMID: 37828380.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    7. Susceptibility-based imaging aids accurate distinction of pediatric-onset MS from myelin oligodendrocyte glycoprotein antibody-associated disease. Mult Scler. 2023 Dec; 29(14):1736-1747. Sacco S, Virupakshaiah A, Papinutto N, Schoeps VA, Akula A, Zhao H, Arona J, Stern WA, Chong J, Hart J, Zamvil SS, Sati P, Henry RG, Waubant E. PMID: 37897254; PMCID: PMC10687802.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    8. A 28-Year-Old Woman With Left-Sided Weakness and Atypical MRI Lesions: From the National Multiple Sclerosis Society Case Conference Proceedings. Neurol Neuroimmunol Neuroinflamm. 2023 11; 10(6). Safadi AL, Osborne B, Chitnis T, Graves JS, Newsome SD, Zamvil SS, Solomon IH, Shin RK. PMID: 37673687; PMCID: PMC10482384.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    9. T cell deletional tolerance restricts AQP4 but not MOG CNS autoimmunity. Proc Natl Acad Sci U S A. 2023 07 25; 120(30):e2306572120. Sagan SA, Moinfar Z, Moseley CE, Dandekar R, Spencer CM, Verkman AS, Ottersen OP, Sobel RA, Sidney J, Sette A, Anderson MS, Steinman L, Wilson MR, Sabatino JJ, Zamvil SS. PMID: 37463205; PMCID: PMC10372680.
      View in: PubMed   Mentions: 2     Fields:    Translation:Animals
    10. Defining blood-induced microglia functions in neurodegeneration through multiomic profiling. Nat Immunol. 2023 07; 24(7):1173-1187. Mendiola AS, Yan Z, Dixit K, Johnson JR, Bouhaddou M, Meyer-Franke A, Shin MG, Yong Y, Agrawal A, MacDonald E, Muthukumar G, Pearce C, Arun N, Cabriga B, Meza-Acevedo R, Alzamora MDPS, Zamvil SS, Pico AR, Ryu JK, Krogan NJ, Akassoglou K. PMID: 37291385; PMCID: PMC10307624.
      View in: PubMed   Mentions: 12     Fields:    Translation:AnimalsCells
    11. A Predictive Autoantibody Signature in Multiple Sclerosis. medRxiv. 2023 May 15. Zamecnik CR, Sowa GM, Abdelhak A, Dandekar R, Bair RD, Wade KJ, Bartley CM, Tubati A, Gomez R, Fouassier C, Gerungan C, Alexander J, Wapniarski AE, Loudermilk RP, Eggers EL, Zorn KC, Ananth K, Jabassini N, Mann SA, Ragan NR, Santaniello A, Henry RG, Baranzini SE, Zamvil SS, Bove RM, Guo CY, Gelfand JM, Cuneo R, von Büdingen HC, Oksenberg JR, Cree BA, Hollenbach JA, Green AJ, Hauser SL, Wallin MT, DeRisi JL, Wilson MR. PMID: 37205595; PMCID: PMC10187343.
      View in: PubMed   Mentions:
    12. Low protection from breakthrough SARS-CoV-2 infection and mild disease course in ocrelizumab-treated patients with multiple sclerosis after three mRNA vaccine doses. J Neurol Neurosurg Psychiatry. 2023 11; 94(11):934-937. Novak F, Bajwa HM, Coia JE, Nilsson AC, Nielsen C, Holm DK, Østergaard K, Hvidt MVM, Byg KE, Johansen IS, Mittl K, Rowles W, Zamvil SS, Bove R, Sabatino JJ, Sejbaek T. PMID: 37185261; PMCID: PMC10579504.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    13. Relapsing Encephalomyelitis After COVID-19 Infection and Vaccination: From the National MS Society Case Conference Proceedings. Neurol Neuroimmunol Neuroinflamm. 2023 05; 10(3). Roy S, Barreras P, Pardo CA, Graves JS, Zamvil SS, Newsome SD. PMID: 37015826; PMCID: PMC10074377.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCellsPHPublic Health
    14. SAkuraBONSAI: Protocol design of a novel, prospective study to explore clinical, imaging, and biomarker outcomes in patients with AQP4-IgG-seropositive neuromyelitis optica spectrum disorder receiving open-label satralizumab. Front Neurol. 2023; 14:1114667. Bennett JL, Fujihara K, Kim HJ, Marignier R, O'Connor KC, Sergott RC, Traboulsee A, Wiendl H, Wuerfel J, Zamvil SS, Anania VG, Buffels R, Künzel T, Lekkerkerker AN, Lennon-Chrimes S, Pittock SJ. PMID: 36873431; PMCID: PMC9982113.
      View in: PubMed   Mentions:
    15. CAR-T Cell-Mediated B-Cell Depletion in Central Nervous System Autoimmunity. Neurol Neuroimmunol Neuroinflamm. 2023 03; 10(2). Gupta S, Simic M, Sagan SA, Shepherd C, Duecker J, Sobel RA, Dandekar R, Wu GF, Wu W, Pak JE, Hauser SL, Lim W, Wilson MR, Zamvil SS. PMID: 36657993; PMCID: PMC9853314.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimalsCells
    16. N2 Year in Review. Neurol Neuroimmunol Neuroinflamm. 2023 Jan; 10(1). Dalmau J, Dalakas MC, Kolson DL, Paul F, Sánchez-Valle R, Zamvil SS. PMID: 36596717.
      View in: PubMed   Mentions: 1     Fields:    
    17. Longitudinal adaptive immune responses following sequential SARS-CoV-2 vaccinations in MS patients on anti-CD20 therapies and sphingosine-1-phosphate receptor modulators. Mult Scler Relat Disord. 2023 Feb; 70:104484. Sabatino JJ, Mittl K, Rowles W, Zamecnik CR, Loudermilk RP, Gerungan C, Spencer CM, Sagan SA, Alexander J, Mcpolin K, Chen P, Deshpande C, Wyse K, Maiese EM, Wilson MR, Zamvil SS, Bove R. PMID: 36608538; PMCID: PMC9794398.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCellsPHPublic Health
    18. MOG Antibody-Associated Disease and Thymic Hyperplasia: From the National Multiple Sclerosis Society Case Conference Proceedings. Neurol Neuroimmunol Neuroinflamm. 2023 03; 10(2). Hurtubise B, Frohman EM, Galetta S, Balcer LJ, Frohman TC, Lisak RP, Newsome SD, Graves JS, Zamvil SS, Amezcua L. PMID: 36517233; PMCID: PMC9753285.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    19. Recurrent Optic Neuritis and Perineuritis Followed by an Unexpected Discovery: From the National Multiple Sclerosis Society Case Conference Proceedings. Neurol Neuroimmunol Neuroinflamm. 2023 01; 10(1). Pimentel Maldonado DA, Lisak R, Galetta S, Balcer L, Varkey T, Goodman A, Graves J, Racke M, Zamvil SS, Newsome S, Frohman EM, Frohman TC. PMID: 36357190.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    20. Multiple Sclerosis Followed by Neuromyelitis Optica Spectrum Disorder: From the National Multiple Sclerosis Society Case Conference Proceedings. Neurol Neuroimmunol Neuroinflamm. 2023 01; 10(1). Goldschmidt C, Galetta SL, Lisak RP, Balcer LJ, Hellman A, Racke MK, Lovett-Racke AE, Cruz R, Parsons MS, Sattarnezhad N, Steinman L, Zamvil SS, Frohman EM, Frohman TC. PMID: 36270950; PMCID: PMC9673749.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    21. Reply to "Spinal Cord Atrophy Is a Preclinical Marker of Progressive MS". Ann Neurol. 2022 05; 91(5):735-736. Bischof A, Papinutto N, Keshavan A, Rajesh A, Kirkish G, Zhang X, Mallott JM, Asteggiano C, Sacco S, Gundel TJ, Zhao C, Stern WA, Caverzasi E, Zhou Y, Gomez R, Ragan NR, Santaniello A, Zhu AH, Juwono J, Bevan CJ, Bove RM, Crabtree-Hartman E, Gelfand JM, Goodin DS, Graves JS, Green AJ, Oksenberg JR, Waubant E, Wilson MR, Zamvil SS, University of California, San Francisco MS-EPIC Team, Cree BA, Hauser SL, Henry RG. PMID: 35233827; PMCID: PMC9511767.
      View in: PubMed   Mentions:    Fields:    
    22. A hormonal therapy for menopausal women with MS: A phase Ib/IIa randomized controlled trial. Mult Scler Relat Disord. 2022 May; 61:103747. Bove R, Anderson A, Rowles W, Rankin KA, Hills NK, Carleton M, Cooper J, Cree BAC, Gelfand JM, Graves JS, Henry RG, Krysko KM, Rush G, Zamvil SS, Joffe H, Chan JR, Green AJ. PMID: 35397292.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    23. Persistently reduced humoral and sustained cellular immune response from first to third SARS-CoV-2 mRNA vaccination in anti-CD20-treated multiple sclerosis patients. Mult Scler Relat Disord. 2022 Apr; 60:103729. Bajwa HM, Novak F, Nilsson AC, Nielsen C, Holm DK, Østergaard K, Witt AH, Byg KE, Johansen IS, Mittl K, Rowles W, Zamvil SS, Bove R, Sabatino JJ, Sejbaek T. PMID: 35334278; PMCID: PMC8898195.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCellsPHPublic Health
    24. Multiple sclerosis therapies differentially affect SARS-CoV-2 vaccine-induced antibody and T cell immunity and function. JCI Insight. 2022 02 22; 7(4). Sabatino JJ, Mittl K, Rowles WM, McPolin K, Rajan JV, Laurie MT, Zamecnik CR, Dandekar R, Alvarenga BD, Loudermilk RP, Gerungan C, Spencer CM, Sagan SA, Augusto DG, Alexander JR, DeRisi JL, Hollenbach JA, Wilson MR, Zamvil SS, Bove R. PMID: 35030101; PMCID: PMC8876469.
      View in: PubMed   Mentions: 44     Fields:    Translation:HumansCells
    25. Spinal Cord Atrophy Predicts Progressive Disease in Relapsing Multiple Sclerosis. Ann Neurol. 2022 02; 91(2):268-281. Bischof A, Papinutto N, Keshavan A, Rajesh A, Kirkish G, Zhang X, Mallott JM, Asteggiano C, Sacco S, Gundel TJ, Zhao C, Stern WA, Caverzasi E, Zhou Y, Gomez R, Ragan NR, Santaniello A, Zhu AH, Juwono J, Bevan CJ, Bove RM, Crabtree E, Gelfand JM, Goodin DS, Graves JS, Green AJ, Oksenberg JR, Waubant E, Wilson MR, Zamvil SS, University of California, San Francisco MS-EPIC Team, Cree BAC, Hauser SL, Henry RG. PMID: 34878197; PMCID: PMC8916838.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    26. Lymph node-resident dendritic cells drive TH2 cell development involving MARCH1. Sci Immunol. 2021 Oct 15; 6(64):eabh0707. Castellanos CA, Ren X, Gonzalez SL, Li HK, Schroeder AW, Liang HE, Laidlaw BJ, Hu D, Mak ACY, Eng C, Rodríguez-Santana JR, LeNoir M, Yan Q, Celedón JC, Burchard EG, Zamvil SS, Ishido S, Locksley RM, Cyster JG, Huang X, Shin JS. PMID: 34652961; PMCID: PMC8736284.
      View in: PubMed   Mentions: 7     Fields:    Translation:AnimalsCells
    27. SARS-CoV-2 spike protein induces abnormal inflammatory blood clots neutralized by fibrin immunotherapy. bioRxiv. 2021 Oct 13. Ryu JK, Sozmen EG, Dixit K, Montano M, Matsui Y, Liu Y, Helmy E, Deerinck TJ, Yan Z, Schuck R, Acevedo RM, Spencer CM, Thomas R, Pico AR, Zamvil SS, Lynch KL, Ellisman MH, Greene WC, Akassoglou K. PMID: 34671772; PMCID: PMC8528086.
      View in: PubMed   Mentions: 1  
    28. Impact of multiple sclerosis disease-modifying therapies on SARS-CoV-2 vaccine-induced antibody and T cell immunity. medRxiv. 2021 Sep 20. Sabatino JJ, Mittl K, Rowles W, Mcpolin K, Rajan JV, Zamecnik CR, Dandekar R, Alvarenga BD, Loudermilk RP, Gerungan C, Spencer CM, Sagan SA, Augusto DG, Alexander J, Hollenbach JA, Wilson MR, Zamvil SS, Bove R. PMID: 34580672; PMCID: PMC8475959.
      View in: PubMed   Mentions:
    29. Humoral immune response following SARS-CoV-2 mRNA vaccination concomitant to anti-CD20 therapy in multiple sclerosis. Mult Scler Relat Disord. 2021 Nov; 56:103251. Novak F, Nilsson AC, Nielsen C, Holm DK, Østergaard K, Bystrup A, Byg KE, Johansen IS, Mittl K, Rowles W, Mcpolin K, Spencer C, Sagan S, Gerungan C, Wilson MR, Zamvil SS, Bove R, Sabatino JJ, Sejbaek T. PMID: 34571415; PMCID: PMC8426319.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCellsPHPublic Health
    30. Encephalitis and Myelitis in a Young Woman: Overlap Syndrome, Thyroiditis, and Occult Tumor From the National Multiple Sclerosis Society Case Conference Proceedings. Neurol Neuroimmunol Neuroinflamm. 2021 07; 8(5). Zarghami Esfanhani N, Wundes A, Varkey T, Lisak RP, Goodman A, Graves J, Zamvil SS, Frohman EM, Frohman TC, Newsome SD. PMID: 34162741; PMCID: PMC8223881.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    31. Can Systemic Anti-CD20 B Cell-Depleting Antibodies Eliminate Meningeal Follicles in Multiple Sclerosis? Neurol Neuroimmunol Neuroinflamm. 2021 07; 8(4). Gupta S, Zamvil SS. PMID: 34001659; PMCID: PMC8130009.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    32. Application of an evidence-based, out-patient treatment strategy for COVID-19: Multidisciplinary medical practice principles to prevent severe disease. J Neurol Sci. 2021 Jul 15; 426:117463. Frohman EM, Villemarette-Pittman NR, Rodriguez A, Glanzman R, Rugheimer S, Komogortsev O, Zamvil SS, Cruz RA, Varkey TC, Frohman AN, Frohman AR, Parsons MS, Konkle EH, Frohman TC. PMID: 33971376; PMCID: PMC8055502.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCellsPHPublic Health
    33. CNS Autoimmune Responses in BCMA-Deficient Mice Provide Insight for the Failure of Atacicept in MS. Neurol Neuroimmunol Neuroinflamm. 2021 05; 8(3). Kumar G, Maria Z, Kohli U, Agasing A, Quinn JL, Ko RM, Zamvil SS, Axtell RC. PMID: 33649164; PMCID: PMC7954465.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimalsCells
    34. Antigen Presentation by B Cells in Multiple Sclerosis. N Engl J Med. 2021 01 28; 384(4):378-381. Zamvil SS, Hauser SL. PMID: 33503348; PMCID: PMC8029120.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    35. A CD8+ NK cell transcriptomic signature associated with clinical outcome in relapsing remitting multiple sclerosis. Nat Commun. 2021 01 27; 12(1):635. McKinney EF, Cuthbertson I, Harris KM, Smilek DE, Connor C, Manferrari G, Carr EJ, Zamvil SS, Smith KGC. PMID: 33504809; PMCID: PMC7840761.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCells
    36. N2 year in review. Neurol Neuroimmunol Neuroinflamm. 2021 01; 8(1). Dalmau J, Dalakas MC, Kolson DL, Paul F, Zamvil SS. PMID: 33411673; PMCID: PMC7757781.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    37. Targeting B cells to modify MS, NMOSD, and MOGAD: Part 2. Neurol Neuroimmunol Neuroinflamm. 2021 01; 8(1). Graf J, Mares J, Barnett M, Aktas O, Albrecht P, Zamvil SS, Hartung HP. PMID: 33411674; PMCID: PMC8063618.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCells
    38. Targeting B Cells to Modify MS, NMOSD, and MOGAD: Part 1. Neurol Neuroimmunol Neuroinflamm. 2021 01; 8(1). Graf J, Mares J, Barnett M, Aktas O, Albrecht P, Zamvil SS, Hartung HP. PMID: 33406479; PMCID: PMC8063619.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansAnimalsCells
    39. Treating MS after surviving PML: Discrete strategies for rescue, remission, and recovery patient 1: From the National Multiple Sclerosis Society Case Conference Proceedings. Neurol Neuroimmunol Neuroinflamm. 2021 01; 8(1). Anadani N, Hyland M, Cruz RA, Lisak R, Costello K, Major EO, Jassam Y, Meltzer E, Varkey TC, Parsons MS, Goodman AD, Graves JS, Newsome S, Zamvil SS, Frohman EM, Frohman TC. PMID: 33411672; PMCID: PMC7803340.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    40. Treating MS after surviving PML: Discrete strategies for rescue, remission, and recovery patient 2: From the National Multiple Sclerosis Society Case Conference Proceedings. Neurol Neuroimmunol Neuroinflamm. 2021 01; 8(1). Cruz RA, Hogan N, Sconzert J, Sconzert M, Major EO, Lisak RP, Melamed E, Varkey TC, Meltzer E, Goodman A, Komogortsev O, Parsons MS, Costello K, Graves JS, Newsome S, Zamvil SS, Frohman EM, Frohman TC. PMID: 33434885; PMCID: PMC7803334.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    41. Neurite Orientation Dispersion and Density Imaging for Assessing Acute Inflammation and Lesion Evolution in MS. AJNR Am J Neuroradiol. 2020 12; 41(12):2219-2226. Sacco S, Caverzasi E, Papinutto N, Cordano C, Bischof A, Gundel T, Cheng S, Asteggiano C, Kirkish G, Mallott J, Stern WA, Bastianello S, Bove RM, Gelfand JM, Goodin DS, Green AJ, Waubant E, Wilson MR, Zamvil SS, Cree BA, Hauser SL, Henry RG, University of California, San Francisco MS-EPIC Team. PMID: 33154077; PMCID: PMC7963254.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    42. The immune signatures of multiple sclerosis: Lessons from twin studies. Proc Natl Acad Sci U S A. 2020 09 29; 117(39):24013-24015. Villoslada P, Zamvil SS. PMID: 32929024; PMCID: PMC7533650.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    43. Ataxin-1 regulates B cell function and the severity of autoimmune experimental encephalomyelitis. Proc Natl Acad Sci U S A. 2020 09 22; 117(38):23742-23750. Didonna A, Canto Puig E, Ma Q, Matsunaga A, Ho B, Caillier SJ, Shams H, Lee N, Hauser SL, Tan Q, Zamvil SS, Oksenberg JR. PMID: 32878998; PMCID: PMC7519225.
      View in: PubMed   Mentions: 8     Fields:    Translation:AnimalsCells
    44. Author Correction: Transcriptional profiling and therapeutic targeting of oxidative stress in neuroinflammation. Nat Immunol. 2020 Sep; 21(9):1135. Mendiola AS, Ryu JK, Bardehle S, Meyer-Franke A, Ang KK, Wilson C, Baeten KM, Hanspers K, Merlini M, Thomas S, Petersen MA, Williams A, Thomas R, Rafalski VA, Meza-Acevedo R, Tognatta R, Yan Z, Pfaff SJ, Machado MR, Bedard C, Coronado PER, Jiang X, Wang J, Pleiss MA, Green AJ, Zamvil SS, Pico AR, Bruneau BG, Arkin MR, Akassoglou K. PMID: 32661365.
      View in: PubMed   Mentions: 2     Fields:    
    45. A pathogenic and clonally expanded B cell transcriptome in active multiple sclerosis. Proc Natl Acad Sci U S A. 2020 09 15; 117(37):22932-22943. Ramesh A, Schubert RD, Greenfield AL, Dandekar R, Loudermilk R, Sabatino JJ, Koelzer MT, Tran EB, Koshal K, Kim K, Pröbstel AK, Banerji D, University of California, San Francisco MS-EPIC Team, Guo CY, Green AJ, Bove RM, DeRisi JL, Gelfand JM, Cree BAC, Zamvil SS, Baranzini SE, Hauser SL, Wilson MR. PMID: 32859762; PMCID: PMC7502747.
      View in: PubMed   Mentions: 71     Fields:    Translation:HumansCells
    46. Mitigating alemtuzumab-associated autoimmunity in MS: A "whack-a-mole" B-cell depletion strategy. Neurol Neuroimmunol Neuroinflamm. 2020 11 05; 7(6). Meltzer E, Campbell S, Ehrenfeld B, Cruz RA, Steinman L, Parsons MS, Zamvil SS, Frohman EM, Frohman TC. PMID: 32769201; PMCID: PMC7643549.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    47. Microglia complement astrocytes in neuromyelitis optica. J Clin Invest. 2020 08 03; 130(8):3961-3964. Moinfar Z, Zamvil SS. PMID: 32568215; PMCID: PMC7410041.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    48. Effect of the sphingosine-1-phosphate receptor modulator ozanimod on leukocyte subtypes in relapsing MS. Neurol Neuroimmunol Neuroinflamm. 2020 09; 7(5). Harris S, Tran JQ, Southworth H, Spencer CM, Cree BAC, Zamvil SS. PMID: 32737072; PMCID: PMC7413711.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCellsCTClinical Trials
    49. Should interferons take front stage as an essential MS disease-modifying therapy in the era of coronavirus disease 2019? Neurol Neuroimmunol Neuroinflamm. 2020 09; 7(5). Maguire C, Frohman T, Zamvil SS, Frohman E, Melamed E. PMID: 32527763; PMCID: PMC7309524.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansPHPublic Health
    50. Part II. high-dose methotrexate with leucovorin rescue for severe COVID-19: An immune stabilization strategy for SARS-CoV-2 induced 'PANIC' attack. J Neurol Sci. 2020 08 15; 415:116935. Frohman EM, Villemarette-Pittman NR, Cruz RA, Longmuir R, Rowe V, Rowe ES, Varkey TC, Steinman L, Zamvil SS, Frohman TC. PMID: 32534807; PMCID: PMC7241359.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCellsPHPublic Health
    51. Part I. SARS-CoV-2 triggered 'PANIC' attack in severe COVID-19. J Neurol Sci. 2020 08 15; 415:116936. Frohman EM, Villemarette-Pittman NR, Melamed E, Cruz RA, Longmuir R, Varkey TC, Steinman L, Zamvil SS, Frohman TC. PMID: 32532449; PMCID: PMC7241348.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCellsPHPublic Health
    52. Transcriptional profiling and therapeutic targeting of oxidative stress in neuroinflammation. Nat Immunol. 2020 05; 21(5):513-524. Mendiola AS, Ryu JK, Bardehle S, Meyer-Franke A, Ang KK, Wilson C, Baeten KM, Hanspers K, Merlini M, Thomas S, Petersen MA, Williams A, Thomas R, Rafalski VA, Meza-Acevedo R, Tognatta R, Yan Z, Pfaff SJ, Machado MR, Bedard C, Rios Coronado PE, Jiang X, Wang J, Pleiss MA, Green AJ, Zamvil SS, Pico AR, Bruneau BG, Arkin MR, Akassoglou K. PMID: 32284594; PMCID: PMC7523413.
      View in: PubMed   Mentions: 69     Fields:    Translation:HumansAnimalsCells
    53. Glatiramer acetate immune modulates B-cell antigen presentation in treatment of MS. Neurol Neuroimmunol Neuroinflamm. 2020 05; 7(3). Häusler D, Hajiyeva Z, Traub JW, Zamvil SS, Lalive PH, Brück W, Weber MS. PMID: 32184341; PMCID: PMC7136047.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansAnimalsCells
    54. New cases of vasculitis after alemtuzumab. Mult Scler. 2020 10; 26(12):1606-1608. Azevedo CJ, Zamvil SS. PMID: 32081067.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    55. Intrathecal B-cell activation in LGI1 antibody encephalitis. Neurol Neuroimmunol Neuroinflamm. 2020 03; 7(2). Lehmann-Horn K, Irani SR, Wang S, Palanichamy A, Jahn S, Greenfield AL, Dandekar R, Lepennetier G, Michael S, Gelfand JM, Geschwind MD, Wilson MR, Zamvil SS, von Büdingen HC. PMID: 32029531; PMCID: PMC7051206.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCells
    56. Reply: Neither human nor mouse is hypercalcaemic with 250 nmol/l 25-hydroxyvitamin D. Brain. 2020 02 01; 143(2):e10. Häusler D, Torke S, Peelen E, Bertsch T, Weber M, Heilmann M, Djukic M, Nau R, Larochelle C, Zamvil SS, Brück W, Weber MS. PMID: 31848576; PMCID: PMC7009594.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimalsCells
    57. Publisher Correction: B cells in autoimmune and neurodegenerative central nervous system diseases. Nat Rev Neurosci. 2020 Jan; 21(1):56. Sabatino JJ, Pröbstel AK, Zamvil SS. PMID: 31772285.
      View in: PubMed   Mentions: 1     Fields:    
    58. N2 year in review. Neurol Neuroimmunol Neuroinflamm. 2020 01; 7(1). Dalmau J, Dalakas MC, Kolson DL, Paul F, Zamvil SS. PMID: 31831570; PMCID: PMC6935839.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    59. Reply: Hypercalcaemia rather than high dose vitamin D3 supplements could exacerbate multiple sclerosis. Brain. 2019 12 01; 142(12):e72. Häusler D, Torke S, Peelen E, Bertsch T, Djukic M, Nau R, Larochelle C, Zamvil SS, Brück W, Weber MS. PMID: 31665230; PMCID: PMC6906588.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    60. Anti-CD20 therapy depletes activated myelin-specific CD8+ T cells in multiple sclerosis. Proc Natl Acad Sci U S A. 2019 12 17; 116(51):25800-25807. Sabatino JJ, Wilson MR, Calabresi PA, Hauser SL, Schneck JP, Zamvil SS. PMID: 31748274; PMCID: PMC6926057.
      View in: PubMed   Mentions: 57     Fields:    Translation:HumansCells
    61. B cells in autoimmune and neurodegenerative central nervous system diseases. Nat Rev Neurosci. 2019 12; 20(12):728-745. Sabatino JJ, Pröbstel AK, Zamvil SS. PMID: 31712781.
      View in: PubMed   Mentions: 126     Fields:    Translation:HumansAnimalsCells
    62. Monitoring retinal changes with optical coherence tomography predicts neuronal loss in experimental autoimmune encephalomyelitis. J Neuroinflammation. 2019 Nov 04; 16(1):203. Cruz-Herranz A, Dietrich M, Hilla AM, Yiu HH, Levin MH, Hecker C, Issberner A, Hallenberger A, Cordano C, Lehmann-Horn K, Balk LJ, Aktas O, Ingwersen J, von Gall C, Hartung HP, Zamvil SS, Fischer D, Albrecht P, Green AJ. PMID: 31684959; PMCID: PMC6827223.
      View in: PubMed   Mentions: 23     Fields:    Translation:AnimalsCells
    63. Do maternal anti-N-methyl-D-aspartate receptor antibodies promote development of neuropsychiatric disease in children? Ann Neurol. 2019 11; 86(5):653-655. Pröbstel AK, Zamvil SS. PMID: 31531881; PMCID: PMC6856826.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimals
    64. High dose vitamin D exacerbates central nervous system autoimmunity by raising T-cell excitatory calcium. Brain. 2019 09 01; 142(9):2737-2755. Häusler D, Torke S, Peelen E, Bertsch T, Djukic M, Nau R, Larochelle C, Zamvil SS, Brück W, Weber MS. PMID: 31302671; PMCID: PMC6736324.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansAnimalsCells
    65. Cataclysmically disseminating neurologic presentation in an immunosuppressed lupus patient: From the National Multiple Sclerosis Society Case Conference Proceedings. Neurol Neuroimmunol Neuroinflamm. 2019 07; 6(4):e582. Perrone CM, Lisak RP, Meltzer EI, Sguigna P, Tizazu E, Jacobs D, Melamed E, Lucas A, Freeman L, Pardo G, Goodman A, Fox EJ, Costello K, Parsons MS, Zamvil SS, Frohman EM, Frohman TC. PMID: 31355318; PMCID: PMC6624090.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    66. Recirculating Intestinal IgA-Producing Cells Regulate Neuroinflammation via IL-10. Cell. 2019 Apr 04; 177(2):492-493. Rojas OL, Pröbstel AK, Porfilio EA, Wang AA, Charabati M, Sun T, Lee DSW, Galicia G, Ramaglia V, Ward LA, Leung LYT, Najafi G, Khaleghi K, Garcillán B, Li A, Besla R, Naouar I, Cao EY, Chiaranunt P, Burrows K, Robinson HG, Allanach JR, Yam J, Luck H, Campbell DJ, Allman D, Brooks DG, Tomura M, Baumann R, Zamvil SS, Bar-Or A, Horwitz MS, Winer DA, Mortha A, Mackay F, Prat A, Osborne LC, Robbins C, Baranzini SE, Gommerman JL. PMID: 30951673.
      View in: PubMed   Mentions: 34     Fields:    
    67. Silent progression in disease activity-free relapsing multiple sclerosis. Ann Neurol. 2019 05; 85(5):653-666. University of California, San Francisco MS-EPIC Team, Cree BAC, Hollenbach JA, Bove R, Kirkish G, Sacco S, Caverzasi E, Bischof A, Gundel T, Zhu AH, Papinutto N, Stern WA, Bevan C, Romeo A, Goodin DS, Gelfand JM, Graves J, Green AJ, Wilson MR, Zamvil SS, Zhao C, Gomez R, Ragan NR, Rush GQ, Barba P, Santaniello A, Baranzini SE, Oksenberg JR, Henry RG, Hauser SL. PMID: 30851128; PMCID: PMC6518998.
      View in: PubMed   Mentions: 130     Fields:    Translation:Humans
    68. Cerebellar syndrome in a man treated with natalizumab: From the National Multiple Sclerosis Society Case Conference Proceedings. Neurol Neuroimmunol Neuroinflamm. 2019 05; 6(3):e546. Lapides DA, Batchala PP, Donahue JH, Lisak RP, Meltzer EI, Narayan RN, Nath A, Frohman TC, Costello K, Goldman MD, Zamvil SS, Frohman EM. PMID: 30882020; PMCID: PMC6410929.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    69. The Evolving Mechanisms of Action of Glatiramer Acetate. Cold Spring Harb Perspect Med. 2019 02 01; 9(2). Prod'homme T, Zamvil SS. PMID: 29440323; PMCID: PMC6360864.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansAnimals
    70. B-Cell Therapies in Multiple Sclerosis. Cold Spring Harb Perspect Med. 2019 02 01; 9(2). Sabatino JJ, Zamvil SS, Hauser SL. PMID: 29358322; PMCID: PMC6360868.
      View in: PubMed   Mentions: 34     Fields:    Translation:HumansCells
    71. Recirculating Intestinal IgA-Producing Cells Regulate Neuroinflammation via IL-10. Cell. 2019 01 24; 176(3):610-624.e18. Rojas OL, Pröbstel AK, Porfilio EA, Wang AA, Charabati M, Sun T, Lee DSW, Galicia G, Ramaglia V, Ward LA, Leung LYT, Najafi G, Khaleghi K, Garcillán B, Li A, Besla R, Naouar I, Cao EY, Chiaranunt P, Burrows K, Robinson HG, Allanach JR, Yam J, Luck H, Campbell DJ, Allman D, Brooks DG, Tomura M, Baumann R, Zamvil SS, Bar-Or A, Horwitz MS, Winer DA, Mortha A, Mackay F, Prat A, Osborne LC, Robbins C, Baranzini SE, Gommerman JL. PMID: 30612739; PMCID: PMC6903689.
      View in: PubMed   Mentions: 123     Fields:    Translation:HumansAnimalsCells
    72. A young man in "double-trouble": Hallucinations and cranial nerve palsies: From the National Multiple Sclerosis Society Case Conference Proceedings. Neurol Neuroimmunol Neuroinflamm. 2019 01; 6(1):e526. Bradshaw MJ, Lisak RP, Meltzer E, Melamed E, Lucas A, Freeman L, Frohman TC, Costello K, Balcer L, Galetta S, Chitnis T, Zamvil SS, Frohman EM. PMID: 30637300; PMCID: PMC6310360.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    73. N2 year in review and message from the editor to our reviewers. Neurol Neuroimmunol Neuroinflamm. 2019 01; 6(1):e525. Dalmau J, Kolson DL, Paul F, Zamvil SS. PMID: 30637299; PMCID: PMC6310359.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    74. Multiple Sclerosis-Associated Changes in the Composition and Immune Functions of Spore-Forming Bacteria. mSystems. 2018 Nov-Dec; 3(6). Cekanaviciute E, Pröbstel AK, Thomann A, Runia TF, Casaccia P, Katz Sand I, Crabtree E, Singh S, Morrissey J, Barba P, Gomez R, Knight R, Mazmanian S, Graves J, Cree BAC, Zamvil SS, Baranzini SE. PMID: 30417113; PMCID: PMC6222044.
      View in: PubMed   Mentions: 33     Fields:    
    75. A young man with numbness in arms and legs: From the National Multiple Sclerosis Society Case Conference Proceedings. Neurol Neuroimmunol Neuroinflamm. 2018 Nov; 5(6):e509. Romeo AR, Lisak RP, Meltzer E, Fox EJ, Melamed E, Lucas A, Freeman L, Frohman TC, Costello K, Zamvil SS, Frohman EM, Gelfand JM. PMID: 30465017; PMCID: PMC6225923.
      View in: PubMed   Mentions: 1     Fields:    
    76. Fibrin-targeting immunotherapy protects against neuroinflammation and neurodegeneration. Nat Immunol. 2018 11; 19(11):1212-1223. Ryu JK, Rafalski VA, Meyer-Franke A, Adams RA, Poda SB, Rios Coronado PE, Pedersen LØ, Menon V, Baeten KM, Sikorski SL, Bedard C, Hanspers K, Bardehle S, Mendiola AS, Davalos D, Machado MR, Chan JP, Plastira I, Petersen MA, Pfaff SJ, Ang KK, Hallenbeck KK, Syme C, Hakozaki H, Ellisman MH, Swanson RA, Zamvil SS, Arkin MR, Zorn SH, Pico AR, Mucke L, Freedman SB, Stavenhagen JB, Nelson RB, Akassoglou K. PMID: 30323343; PMCID: PMC6317891.
      View in: PubMed   Mentions: 90     Fields:    Translation:HumansAnimals
    77. T cells take aim at a ubiquitous autoantigen in multiple sclerosis. Sci Transl Med. 2018 10 10; 10(462). Sabatino JJ, Zamvil SS. PMID: 30305455.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    78. Functional characterization of reappearing B cells after anti-CD20 treatment of CNS autoimmune disease. Proc Natl Acad Sci U S A. 2018 09 25; 115(39):9773-9778. Häusler D, Häusser-Kinzel S, Feldmann L, Torke S, Lepennetier G, Bernard CCA, Zamvil SS, Brück W, Lehmann-Horn K, Weber MS. PMID: 30194232; PMCID: PMC6166805.
      View in: PubMed   Mentions: 48     Fields:    Translation:AnimalsCells
    79. Vascular niche IL-6 induces alternative macrophage activation in glioblastoma through HIF-2α. Nat Commun. 2018 02 08; 9(1):559. Wang Q, He Z, Huang M, Liu T, Wang Y, Xu H, Duan H, Ma P, Zhang L, Zamvil SS, Hidalgo J, Zhang Z, O'Rourke DM, Dahmane N, Brem S, Mou Y, Gong Y, Fan Y. PMID: 29422647; PMCID: PMC5805734.
      View in: PubMed   Mentions: 107     Fields:    Translation:HumansAnimalsCells
    80. The Gut Microbiome in Neuromyelitis Optica. Neurotherapeutics. 2018 01; 15(1):92-101. Zamvil SS, Spencer CM, Baranzini SE, Cree BAC. PMID: 29280091; PMCID: PMC5794705.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansAnimalsCells
    81. Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4. J Vis Exp. 2017 08 21; (126). Sagan SA, Cruz-Herranz A, Spencer CM, Ho PP, Steinman L, Green AJ, Sobel RA, Zamvil SS. PMID: 28872108; PMCID: PMC5614352.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimalsCells
    82. Aryl hydrocarbon receptor activity may serve as a surrogate marker for MS disease activity. Neurol Neuroimmunol Neuroinflamm. 2017 Jul; 4(4):e366. Sabatino JJ, Zamvil SS. PMID: 28642890; PMCID: PMC5473954.
      View in: PubMed   Mentions: 2     Fields:    
    83. Acute liver injury in a Glatopa-treated patient with MS. Neurol Neuroimmunol Neuroinflamm. 2017 Jul; 4(4):e368. Sabatino JJ, Mehta NJ, Kakar S, Zamvil SS, Cree BAC. PMID: 28626784; PMCID: PMC5459788.
      View in: PubMed   Mentions: 2     Fields:    
    84. T cells targeting neuromyelitis optica autoantigen aquaporin-4 cause paralysis and visual system injury. J Nat Sci. 2017 May; 3(5). Cruz-Herranz A, Sagan SA, Sobel RA, Green AJ, Zamvil SS. PMID: 28748216; PMCID: PMC5523104.
      View in: PubMed   Mentions: 6  
    85. Tolerance checkpoint bypass permits emergence of pathogenic T cells to neuromyelitis optica autoantigen aquaporin-4. Proc Natl Acad Sci U S A. 2016 12 20; 113(51):14781-14786. Sagan SA, Winger RC, Cruz-Herranz A, Nelson PA, Hagberg S, Miller CN, Spencer CM, Ho PP, Bennett JL, Levy M, Levin MH, Verkman AS, Steinman L, Green AJ, Anderson MS, Sobel RA, Zamvil SS. PMID: 27940915; PMCID: PMC5187685.
      View in: PubMed   Mentions: 39     Fields:    Translation:AnimalsCells
    86. B cell repertoire expansion occurs in meningeal ectopic lymphoid tissue. JCI Insight. 2016 12 08; 1(20):e87234. Lehmann-Horn K, Wang SZ, Sagan SA, Zamvil SS, von Büdingen HC. PMID: 27942581; PMCID: PMC5135275.
      View in: PubMed   Mentions: 34     Fields:    Translation:AnimalsCells
    87. Accelerated remyelination during inflammatory demyelination prevents axonal loss and improves functional recovery. Elife. 2016 Sep 27; 5. Mei F, Lehmann-Horn K, Shen YA, Rankin KA, Stebbins KJ, Lorrain DS, Pekarek K, A Sagan S, Xiao L, Teuscher C, von Büdingen HC, Wess J, Lawrence JJ, Green AJ, Fancy SP, Zamvil SS, Chan JR. PMID: 27671734; PMCID: PMC5039026.
      View in: PubMed   Mentions: 126     Fields:    
    88. Associations between the gut microbiota and host immune markers in pediatric multiple sclerosis and controls. BMC Neurol. 2016 Sep 21; 16(1):182. Tremlett H, Fadrosh DW, Faruqi AA, Hart J, Roalstad S, Graves J, Spencer CM, Lynch SV, Zamvil SS, Waubant E, US Network of Pediatric MS Centers. PMID: 27652609; PMCID: PMC5031272.
      View in: PubMed   Mentions: 55     Fields:    
    89. Treatment of spontaneous EAE by laquinimod reduces Tfh, B cell aggregates, and disease progression. Neurol Neuroimmunol Neuroinflamm. 2016 Oct; 3(5):e272. Varrin-Doyer M, Pekarek KL, Spencer CM, Bernard CC, Sobel RA, Cree BA, Schulze-Topphoff U, Zamvil SS. PMID: 27704036; PMCID: PMC5032667.
      View in: PubMed   Mentions: 26     Fields:    
    90. Restoring immune tolerance in neuromyelitis optica: Part I. Neurol Neuroimmunol Neuroinflamm. 2016 Oct; 3(5):e276. Steinman L, Bar-Or A, Behne JM, Benitez-Ribas D, Chin PS, Clare-Salzler M, Healey D, Kim JI, Kranz DM, Lutterotti A, Martin R, Schippling S, Villoslada P, Wei CH, Weiner HL, Zamvil SS, Yeaman MR, Smith TJ. PMID: 27648463; PMCID: PMC5015539.
      View in: PubMed   Mentions: 19     Fields:    
    91. Restoring immune tolerance in neuromyelitis optica: Part II. Neurol Neuroimmunol Neuroinflamm. 2016 Oct; 3(5):e277. Bar-Or A, Steinman L, Behne JM, Benitez-Ribas D, Chin PS, Clare-Salzler M, Healey D, Kim JI, Kranz DM, Lutterotti A, Martin R, Schippling S, Villoslada P, Wei CH, Weiner HL, Zamvil SS, Smith TJ, Yeaman MR. PMID: 27648464; PMCID: PMC5015540.
      View in: PubMed   Mentions: 15     Fields:    
    92. Long-term evolution of multiple sclerosis disability in the treatment era. Ann Neurol. 2016 10; 80(4):499-510. University of California, San Francisco MS-EPIC Team:, Cree BA, Gourraud PA, Oksenberg JR, Bevan C, Crabtree-Hartman E, Gelfand JM, Goodin DS, Graves J, Green AJ, Mowry E, Okuda DT, Pelletier D, von Büdingen HC, Zamvil SS, Agrawal A, Caillier S, Ciocca C, Gomez R, Kanner R, Lincoln R, Lizee A, Qualley P, Santaniello A, Suleiman L, Bucci M, Panara V, Papinutto N, Stern WA, Zhu AH, Cutter GR, Baranzini S, Henry RG, Hauser SL. PMID: 27464262; PMCID: PMC5105678.
      View in: PubMed   Mentions: 140     Fields:    Translation:Humans
    93. Gut microbiome analysis in neuromyelitis optica reveals overabundance of Clostridium perfringens. Ann Neurol. 2016 09; 80(3):443-7. Cree BA, Spencer CM, Varrin-Doyer M, Baranzini SE, Zamvil SS. PMID: 27398819; PMCID: PMC5053302.
      View in: PubMed   Mentions: 59     Fields:    Translation:HumansCells
    94. Your nose knows how to target brain inflammation. Brain. 2016 07; 139(Pt 7):1866-9. Winger RC, Zamvil SS. PMID: 27343218; PMCID: PMC4939693.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    95. Antibodies in multiple sclerosis oligoclonal bands target debris. Proc Natl Acad Sci U S A. 2016 07 12; 113(28):7696-8. Winger RC, Zamvil SS. PMID: 27357674; PMCID: PMC4948325.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    96. Beginning of the end of two-stage theory purporting that inflammation then degeneration explains pathogenesis of progressive multiple sclerosis. Curr Opin Neurol. 2016 06; 29(3):340-4. Steinman L, Zamvil SS. PMID: 27027554.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    97. Dimethyl fumarate treatment induces adaptive and innate immune modulation independent of Nrf2. Proc Natl Acad Sci U S A. 2016 Apr 26; 113(17):4777-82. Schulze-Topphoff U, Varrin-Doyer M, Pekarek K, Spencer CM, Shetty A, Sagan SA, Cree BA, Sobel RA, Wipke BT, Steinman L, Scannevin RH, Zamvil SS. PMID: 27078105; PMCID: PMC4855599.
      View in: PubMed   Mentions: 130     Fields:    Translation:AnimalsCells
    98. CNS accumulation of regulatory B cells is VLA-4-dependent. Neurol Neuroimmunol Neuroinflamm. 2016 Apr; 3(2):e212. Lehmann-Horn K, Sagan SA, Winger RC, Spencer CM, Bernard CC, Sobel RA, Zamvil SS. PMID: 27027096; PMCID: PMC4794810.
      View in: PubMed   Mentions: 22     Fields:    
    99. Glatiramer acetate treatment negatively regulates type I interferon signaling. Neurol Neuroimmunol Neuroinflamm. 2015 Dec; 2(6):e179. Molnarfi N, Prod'homme T, Schulze-Topphoff U, Spencer CM, Weber MS, Patarroyo JC, Lalive PH, Zamvil SS. PMID: 26601118; PMCID: PMC4645172.
      View in: PubMed   Mentions: 11     Fields:    
    100. Vitamin D in clinically isolated syndrome: evidence for possible neuroprotection. Eur J Neurol. 2016 Feb; 23(2):327-32. Mowry EM, Pelletier D, Gao Z, Howell MD, Zamvil SS, Waubant E. PMID: 26518224.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    101. Blood coagulation protein fibrinogen promotes autoimmunity and demyelination via chemokine release and antigen presentation. Nat Commun. 2015 Sep 10; 6:8164. Ryu JK, Petersen MA, Murray SG, Baeten KM, Meyer-Franke A, Chan JP, Vagena E, Bedard C, Machado MR, Rios Coronado PE, Prod'homme T, Charo IF, Lassmann H, Degen JL, Zamvil SS, Akassoglou K. PMID: 26353940; PMCID: PMC4579523.
      View in: PubMed   Mentions: 138     Fields:    Translation:AnimalsCells
    102. Unique invariant CD8(+) T cell population persists in MS. Neurol Neuroimmunol Neuroinflamm. 2015 Aug; 2(4):e140. Sabatino JJ, Zamvil SS. PMID: 26280013; PMCID: PMC4529280.
      View in: PubMed   Mentions:    Fields:    
    103. Update on biomarkers in neuromyelitis optica. Neurol Neuroimmunol Neuroinflamm. 2015 Aug; 2(4):e134. Melamed E, Levy M, Waters PJ, Sato DK, Bennett JL, John GR, Hooper DC, Saiz A, Bar-Or A, Kim HJ, Pandit L, Leite MI, Asgari N, Kissani N, Hintzen R, Marignier R, Jarius S, Marcelletti J, Smith TJ, Yeaman MR, Han MH, Aktas O, Apiwattanakul M, Banwell B, Bichuetti D, Broadley S, Cabre P, Chitnis T, De Seze J, Fujihara K, Greenberg B, Hellwig K, Iorio R, Jarius S, Klawiter E, Kleiter I, Lana-Peixoto M, O'Connor K, Palace J, Paul F, Prayoonwiwat N, Ruprecht K, Stuve O, Tedder T, Tenembaum S, Garrahan JP, Aires B, van Herle K, van Pelt D, Villoslada P, Waubant E, Weinshenker B, Wingerchuk D, Würfel J, Zamvil S. PMID: 26236760; PMCID: PMC4516398.
      View in: PubMed   Mentions: 44     Fields:    
    104. Use of Advanced Magnetic Resonance Imaging Techniques in Neuromyelitis Optica Spectrum Disorder. JAMA Neurol. 2015 Jul; 72(7):815-22. Kremer S, Renard F, Achard S, Lana-Peixoto MA, Palace J, Asgari N, Klawiter EC, Tenembaum SN, Banwell B, Greenberg BM, Bennett JL, Levy M, Villoslada P, Saiz A, Fujihara K, Chan KH, Schippling S, Paul F, Kim HJ, de Seze J, Wuerfel JT, Guthy-Jackson Charitable Foundation (GJCF) Neuromyelitis Optica (NMO) International Clinical Consort, Cabre P, Marignier R, Tedder T, van Pelt D, Broadley S, Chitnis T, Wingerchuk D, Pandit L, Leite MI, Apiwattanakul M, Kleiter I, Prayoonwiwat N, Han M, Hellwig K, van Herle K, John G, Hooper DC, Nakashima I, Sato D, Yeaman MR, Waubant E, Zamvil S, Stüve O, Aktas O, Smith TJ, Jacob A, O'Connor K. PMID: 26010909; PMCID: PMC4828237.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    105. Erratum: The ubiquitin-modifying enzyme A20 restricts ubiquitination of the kinase RIPK3 and protects cells from necroptosis. Nat Immunol. 2015 Jul; 16(7):785. Onizawa M, Oshima S, Schulze-Topphoff U, Oses-Prieto JA, Lu T, Tavares R, Prodhomme T, Duong B, Whang MI, Advincula R, Agelidis A, Barrera J, Wu H, Burlingame A, Malynn BA, Zamvil SS, Ma A. PMID: 26086145; PMCID: PMC4881846.
      View in: PubMed   Mentions: 2     Fields:    
    106. B lymphocytes in neuromyelitis optica. Neurol Neuroimmunol Neuroinflamm. 2015 Jun; 2(3):e104. Bennett JL, O'Connor KC, Bar-Or A, Zamvil SS, Hemmer B, Tedder TF, von Büdingen HC, Stuve O, Yeaman MR, Smith TJ, Stadelmann C. PMID: 25977932; PMCID: PMC4426682.
      View in: PubMed   Mentions: 70     Fields:    
    107. The ubiquitin-modifying enzyme A20 restricts ubiquitination of the kinase RIPK3 and protects cells from necroptosis. Nat Immunol. 2015 Jun; 16(6):618-27. Onizawa M, Oshima S, Schulze-Topphoff U, Oses-Prieto JA, Lu T, Tavares R, Prodhomme T, Duong B, Whang MI, Advincula R, Agelidis A, Barrera J, Wu H, Burlingame A, Malynn BA, Zamvil SS, Ma A. PMID: 25939025; PMCID: PMC4439357.
      View in: PubMed   Mentions: 152     Fields:    Translation:HumansAnimalsCells
    108. B-cell very late antigen-4 deficiency reduces leukocyte recruitment and susceptibility to central nervous system autoimmunity. Ann Neurol. 2015 May; 77(5):902-8. Lehmann-Horn K, Sagan SA, Bernard CC, Sobel RA, Zamvil SS. PMID: 25712734; PMCID: PMC4405474.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansAnimalsCells
    109. Update on the autoimmune pathology of multiple sclerosis: B-cells as disease-drivers and therapeutic targets. Eur Neurol. 2015; 73(3-4):238-246. von Büdingen HC, Palanichamy A, Lehmann-Horn K, Michel BA, Zamvil SS. PMID: 25824054; PMCID: PMC4401636.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansAnimalsCells
    110. Reduction of CD8(+) T lymphocytes in multiple sclerosis patients treated with dimethyl fumarate. Neurol Neuroimmunol Neuroinflamm. 2015 Jun; 2(3):e76. Spencer CM, Crabtree-Hartman EC, Lehmann-Horn K, Cree BA, Zamvil SS. PMID: 25738172; PMCID: PMC4335821.
      View in: PubMed   Mentions: 96     Fields:    
    111. Does MOG Ig-positive AQP4-seronegative opticospinal inflammatory disease justify a diagnosis of NMO spectrum disorder? Neurol Neuroimmunol Neuroinflamm. 2015 Feb; 2(1):e62. Zamvil SS, Slavin AJ. PMID: 25635259; PMCID: PMC4309526.
      View in: PubMed   Mentions: 129     Fields:    
    112. Precision medicine in chronic disease management: The multiple sclerosis BioScreen. Ann Neurol. 2014 Nov; 76(5):633-42. Gourraud PA, Henry RG, Cree BA, Crane JC, Lizee A, Olson MP, Santaniello AV, Datta E, Zhu AH, Bevan CJ, Gelfand JM, Graves JS, Goodin DS, Green AJ, von Büdingen HC, Waubant E, Zamvil SS, Crabtree-Hartman E, Nelson S, Baranzini SE, Hauser SL. PMID: 25263997; PMCID: PMC4214886.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    113. Immunodominant T-cell epitopes of MOG reside in its transmembrane and cytoplasmic domains in EAE. Neurol Neuroimmunol Neuroinflamm. 2014 Aug; 1(2):e22. Shetty A, Gupta SG, Varrin-Doyer M, Weber MS, Prod'homme T, Molnarfi N, Ji N, Nelson PA, Patarroyo JC, Schulze-Topphoff U, Fogal SE, Forsthuber T, Sobel RA, Bernard CC, Slavin AJ, Zamvil SS. PMID: 25340074; PMCID: PMC4202928.
      View in: PubMed   Mentions: 21     Fields:    
    114. MOG transmembrane and cytoplasmic domains contain highly stimulatory T-cell epitopes in MS. Neurol Neuroimmunol Neuroinflamm. 2014 Aug; 1(2):e20. Varrin-Doyer M, Shetty A, Spencer CM, Schulze-Topphoff U, Weber MS, Bernard CC, Forsthuber T, Cree BA, Slavin AJ, Zamvil SS. PMID: 25340072; PMCID: PMC4202926.
      View in: PubMed   Mentions: 16     Fields:    
    115. Laquinimod, an up-and-coming immunomodulatory agent for treatment of multiple sclerosis. Exp Neurol. 2014 Dec; 262 Pt A:66-71. Varrin-Doyer M, Zamvil SS, Schulze-Topphoff U. PMID: 24731945; PMCID: PMC4195809.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansAnimals
    116. Neither T-helper type 2 nor Foxp3+ regulatory T cells are necessary for therapeutic benefit of atorvastatin in treatment of central nervous system autoimmunity. J Neuroinflammation. 2014 Feb 06; 11:29. Weber MS, Prod'homme T, Youssef S, Dunn SE, Steinman L, Zamvil SS. PMID: 24498870; PMCID: PMC3922392.
      View in: PubMed   Mentions: 11     Fields:    Translation:AnimalsCells
    117. MHC class II-dependent B cell APC function is required for induction of CNS autoimmunity independent of myelin-specific antibodies. J Exp Med. 2013 Dec 16; 210(13):2921-37. Molnarfi N, Schulze-Topphoff U, Weber MS, Patarroyo JC, Prod'homme T, Varrin-Doyer M, Shetty A, Linington C, Slavin AJ, Hidalgo J, Jenne DE, Wekerle H, Sobel RA, Bernard CC, Shlomchik MJ, Zamvil SS. PMID: 24323356; PMCID: PMC3865476.
      View in: PubMed   Mentions: 202     Fields:    Translation:AnimalsCells
    118. Therapeutic decisions in multiple sclerosis: moving beyond efficacy. JAMA Neurol. 2013 Oct; 70(10):1315-24. Brück W, Gold R, Lund BT, Oreja-Guevara C, Prat A, Spencer CM, Steinman L, Tintoré M, Vollmer TL, Weber MS, Weiner LP, Ziemssen T, Zamvil SS. PMID: 23921521; PMCID: PMC4106803.
      View in: PubMed   Mentions: 52     Fields:    Translation:Humans
    119. Tob1 plays a critical role in the activation of encephalitogenic T cells in CNS autoimmunity. J Exp Med. 2013 Jul 01; 210(7):1301-9. Schulze-Topphoff U, Casazza S, Varrin-Doyer M, Pekarek K, Sobel RA, Hauser SL, Oksenberg JR, Zamvil SS, Baranzini SE. PMID: 23797093; PMCID: PMC3698524.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansAnimalsCells
    120. Developmental maturation of innate immune cell function correlates with susceptibility to central nervous system autoimmunity. Eur J Immunol. 2013 Aug; 43(8):2078-88. Hertzenberg D, Lehmann-Horn K, Kinzel S, Husterer V, Cravens PD, Kieseier BC, Hemmer B, Brück W, Zamvil SS, Stüve O, Weber MS. PMID: 23637087; PMCID: PMC4136766.
      View in: PubMed   Mentions: 7     Fields:    Translation:AnimalsCells
    121. The neonatal CNS is not conducive for encephalitogenic Th1 T cells and B cells during experimental autoimmune encephalomyelitis. J Neuroinflammation. 2013 May 24; 10:67. Cravens PD, Kieseier BC, Hussain R, Herndon E, Arellano B, Ben LH, Timmons BC, Castro-Rojas C, Hartung HP, Hemmer B, Weber MS, Zamvil SS, Stüve O. PMID: 23705890; PMCID: PMC3679999.
      View in: PubMed   Mentions: 6     Fields:    Translation:AnimalsCells
    122. Aquaporin 4-specific T cells in neuromyelitis optica exhibit a Th17 bias and recognize Clostridium ABC transporter. Ann Neurol. 2012 Jul; 72(1):53-64. Varrin-Doyer M, Spencer CM, Schulze-Topphoff U, Nelson PA, Stroud RM, Cree BA, Zamvil SS. PMID: 22807325; PMCID: PMC3405197.
      View in: PubMed   Mentions: 156     Fields:    Translation:HumansCells
    123. Laquinimod, a once-daily oral drug in development for the treatment of relapsing-remitting multiple sclerosis. Expert Rev Clin Pharmacol. 2012 May; 5(3):245-56. Brück W, Zamvil SS. PMID: 22697588.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansAnimals
    124. K+ channel alterations in the progression of experimental autoimmune encephalomyelitis. Neurobiol Dis. 2012 Aug; 47(2):280-93. Jukkola PI, Lovett-Racke AE, Zamvil SS, Gu C. PMID: 22560931; PMCID: PMC3367054.
      View in: PubMed   Mentions: 26     Fields:    Translation:AnimalsCells
    125. Laquinimod, a quinoline-3-carboxamide, induces type II myeloid cells that modulate central nervous system autoimmunity. PLoS One. 2012; 7(3):e33797. Schulze-Topphoff U, Shetty A, Varrin-Doyer M, Molnarfi N, Sagan SA, Sobel RA, Nelson PA, Zamvil SS. PMID: 22479444; PMCID: PMC3316495.
      View in: PubMed   Mentions: 45     Fields:    Translation:AnimalsCells
    126. Randomized controlled trial of atorvastatin in clinically isolated syndrome: the STAyCIS study. Neurology. 2012 Apr 10; 78(15):1171-8. Waubant E, Pelletier D, Mass M, Cohen JA, Kita M, Cross A, Bar-Or A, Vollmer T, Racke M, Stüve O, Schwid S, Goodman A, Kachuck N, Preiningerova J, Weinstock-Guttman B, Calabresi PA, Miller A, Mokhtarani M, Iklé D, Murphy S, Kopetskie H, Ding L, Rosenberg E, Spencer C, Zamvil SS, ITN STAyCIS Study Group, ITN020AI Study Management Team. PMID: 22459680; PMCID: PMC3320055.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCTClinical Trials
    127. Re-engineering of pathogenic aquaporin 4-specific antibodies as molecular decoys to treat neuromyelitis optica. Ann Neurol. 2012 Mar; 71(3):287-8. Steinman L, Zamvil SS. PMID: 22451198.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimals
    128. B cells in multiple sclerosis: connecting the dots. Curr Opin Immunol. 2011 Dec; 23(6):713-20. von Büdingen HC, Bar-Or A, Zamvil SS. PMID: 21983151; PMCID: PMC4188435.
      View in: PubMed   Mentions: 42     Fields:    Translation:HumansAnimalsCells
    129. Combining statins with interferon β in multiple sclerosis: think twice, it might not be all right. Lancet Neurol. 2011 Aug; 10(8):672-3. Zamvil SS, Steinman L. PMID: 21742557; PMCID: PMC4106800.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    130. Lymph node-derived donor encephalitogenic CD4+ T cells in C57BL/6 mice adoptive transfer experimental autoimmune encephalomyelitis highly express GM-CSF and T-bet. J Neuroinflammation. 2011 Jun 24; 8:73. Cravens PD, Hussain RZ, Zacharias TE, Ben LH, Herndon E, Vinnakota R, Lambracht-Washington D, Nessler S, Zamvil SS, Eagar TN, Stüve O. PMID: 21702922; PMCID: PMC3161869.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansAnimalsCells
    131. Accelerated central nervous system autoimmunity in BAFF-receptor-deficient mice. J Neurol Sci. 2011 Jul 15; 306(1-2):9-15. Kim SS, Richman DP, Zamvil SS, Agius MA. PMID: 21529843; PMCID: PMC4172440.
      View in: PubMed   Mentions: 12     Fields:    Translation:AnimalsCells
    132. Glatiramer acetate in the treatment of multiple sclerosis: emerging concepts regarding its mechanism of action. CNS Drugs. 2011 May; 25(5):401-14. Lalive PH, Neuhaus O, Benkhoucha M, Burger D, Hohlfeld R, Zamvil SS, Weber MS. PMID: 21476611; PMCID: PMC3963480.
      View in: PubMed   Mentions: 78     Fields:    Translation:HumansAnimals
    133. Switching multiple sclerosis patients with breakthrough disease to second-line therapy. PLoS One. 2011 Feb 03; 6(2):e16664. Castillo-Trivino T, Mowry EM, Gajofatto A, Chabas D, Crabtree-Hartman E, Cree BA, Goodin DS, Green AJ, Okuda DT, Pelletier D, Zamvil SS, Vittinghoff E, Waubant E. PMID: 21304907; PMCID: PMC3033401.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    134. Proinflammatory role of aquaporin-4 in autoimmune neuroinflammation. FASEB J. 2011 May; 25(5):1556-66. Li L, Zhang H, Varrin-Doyer M, Zamvil SS, Verkman AS. PMID: 21257712; PMCID: PMC3079299.
      View in: PubMed   Mentions: 92     Fields:    Translation:AnimalsCells
    135. Repetitive pertussis toxin promotes development of regulatory T cells and prevents central nervous system autoimmune disease. PLoS One. 2010 Dec 30; 5(12):e16009. Weber MS, Benkhoucha M, Lehmann-Horn K, Hertzenberg D, Sellner J, Santiago-Raber ML, Chofflon M, Hemmer B, Zamvil SS, Lalive PH. PMID: 21209857; PMCID: PMC3012729.
      View in: PubMed   Mentions: 12     Fields:    Translation:AnimalsCells
    136. Immunodominant T cell determinants of aquaporin-4, the autoantigen associated with neuromyelitis optica. PLoS One. 2010 Nov 30; 5(11):e15050. Nelson PA, Khodadoust M, Prodhomme T, Spencer C, Patarroyo JC, Varrin-Doyer M, Ho JD, Stroud RM, Zamvil SS. PMID: 21151500; PMCID: PMC2994828.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    137. Delivery of myelin peptides through the first line of defense, skin, to counter autoimmunity in multiple sclerosis. Ann Neurol. 2010 Nov; 68(5):567-9. Steinman L, Zamvil SS. PMID: 21031570.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    138. B-cell activation influences T-cell polarization and outcome of anti-CD20 B-cell depletion in central nervous system autoimmunity. Ann Neurol. 2010 Sep; 68(3):369-83. Weber MS, Prod'homme T, Patarroyo JC, Molnarfi N, Karnezis T, Lehmann-Horn K, Danilenko DM, Eastham-Anderson J, Slavin AJ, Linington C, Bernard CC, Martin F, Zamvil SS. PMID: 20641064; PMCID: PMC3375897.
      View in: PubMed   Mentions: 160     Fields:    Translation:HumansAnimalsCells
    139. Natalizumab and progressive multifocal leukoencephalopathy: what are the causal factors and can it be avoided? Arch Neurol. 2010 Aug; 67(8):923-30. Warnke C, Menge T, Hartung HP, Racke MK, Cravens PD, Bennett JL, Frohman EM, Greenberg BM, Zamvil SS, Gold R, Hemmer B, Kieseier BC, Stüve O. PMID: 20697042; PMCID: PMC4157908.
      View in: PubMed   Mentions: 47     Fields:    Translation:Humans
    140. TLR-mediated B cell activation results in ectopic CLIP expression that promotes B cell-dependent inflammation. J Leukoc Biol. 2010 Oct; 88(4):779-89. Newell MK, Tobin RP, Cabrera JH, Sorensen MB, Huckstep A, Villalobos-Menuey EM, Burnett M, McCrea E, Harvey CP, Buddiga A, Bar-Or A, Freedman MS, Nalbantoglu J, Arbour N, Zamvil SS, Antel JP. PMID: 20631258; PMCID: PMC3218675.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansAnimalsCells
    141. Translational research in neurology and neuroscience 2010: multiple sclerosis. Arch Neurol. 2010 Nov; 67(11):1307-15. Stüve O, Kieseier BC, Hemmer B, Hartung HP, Awad A, Frohman EM, Greenberg BM, Racke MK, Zamvil SS, Phillips JT, Gold R, Chan A, Zettl U, Milo R, Marder E, Khan O, Eagar TN. PMID: 20625066; PMCID: PMC3670826.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimals
    142. FTY720 and central memory: out of sight, out of mind. Neurology. 2010 Aug 03; 75(5):388-9. Slavin AJ, Zamvil SS. PMID: 20610831.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    143. Depletion of B lymphocytes from cerebral perivascular spaces by rituximab. Arch Neurol. 2009 Aug; 66(8):1016-20. Martin Mdel P, Cravens PD, Winger R, Kieseier BC, Cepok S, Eagar TN, Zamvil SS, Weber MS, Frohman EM, Kleinschmidt-Demasters BK, Montine TJ, Hemmer B, Marra CM, Stüve O. PMID: 19667224.
      View in: PubMed   Mentions: 46     Fields:    Translation:HumansCells
    144. Glatiramer acetate increases IL-1 receptor antagonist but decreases T cell-induced IL-1beta in human monocytes and multiple sclerosis. Proc Natl Acad Sci U S A. 2009 Mar 17; 106(11):4355-9. Burger D, Molnarfi N, Weber MS, Brandt KJ, Benkhoucha M, Gruaz L, Chofflon M, Zamvil SS, Lalive PH. PMID: 19255448; PMCID: PMC2649955.
      View in: PubMed   Mentions: 78     Fields:    Translation:HumansAnimalsCells
    145. Genotype-Phenotype correlations in multiple sclerosis: HLA genes influence disease severity inferred by 1HMR spectroscopy and MRI measures. Brain. 2009 Jan; 132(Pt 1):250-9. Okuda DT, Srinivasan R, Oksenberg JR, Goodin DS, Baranzini SE, Beheshtian A, Waubant E, Zamvil SS, Leppert D, Qualley P, Lincoln R, Gomez R, Caillier S, George M, Wang J, Nelson SJ, Cree BA, Hauser SL, Pelletier D. PMID: 19022862; PMCID: PMC2638695.
      View in: PubMed   Mentions: 53     Fields:    Translation:Humans
    146. Decrease in the numbers of dendritic cells and CD4+ T cells in cerebral perivascular spaces due to natalizumab. Arch Neurol. 2008 Dec; 65(12):1596-603. del Pilar Martin M, Cravens PD, Winger R, Frohman EM, Racke MK, Eagar TN, Zamvil SS, Weber MS, Hemmer B, Karandikar NJ, Kleinschmidt-DeMasters BK, Stüve O. PMID: 18852339.
      View in: PubMed   Mentions: 72     Fields:    Translation:HumansCells
    147. Glatiramer acetate treatment does not modify the clinical course of (NZB x BXSB)F1 lupus murine model. Int Immunol. 2008 Oct; 20(10):1313-9. Borel P, Benkhoucha M, Weber MS, Zamvil SS, Santiago-Raber ML, Lalive PH. PMID: 18687587.
      View in: PubMed   Mentions: 5     Fields:    Translation:AnimalsCells
    148. Bench to bedside: tempering antigen-presenting cells in multiple sclerosis. Nat Med. 2008 Jun; 14(6):614-5. Prod'homme T, Zamvil SS. PMID: 18535577.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    149. Disease-modifying agents for multiple sclerosis: recent advances and future prospects. Drugs. 2008; 68(17):2445-68. Menge T, Weber MS, Hemmer B, Kieseier BC, von Büdingen HC, Warnke C, Zamvil SS, Boster A, Khan O, Hartung HP, Stüve O. PMID: 19016573.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    150. Pharmacological treatment of early multiple sclerosis. Drugs. 2008; 68(1):73-83. Stüve O, Bennett JL, Hemmer B, Wiendl H, Racke MK, Bar-Or A, Hu W, Zivadinov R, Weber MS, Zamvil SS, Pacheco MF, Menge T, Hartung HP, Kieseier BC, Frohman EM. PMID: 18081373.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    151. Statins and demyelination. Curr Top Microbiol Immunol. 2008; 318:313-24. Weber MS, Zamvil SS. PMID: 18219823.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimals
    152. The immunogenicity of disease-modifying therapies for multiple sclerosis: clinical implications for neurologists. Neurologist. 2007 Nov; 13(6):355-62. Fox EJ, Vartanian TK, Zamvil SS. PMID: 18090713.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    153. Neuroimmunotherapeutics comes of age. Neurotherapeutics. 2007 Oct; 4(4):569-70. Ransohoff RM, Zamvil SS. PMID: 17920537; PMCID: PMC7479683.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    154. Mechanism of action of glatiramer acetate in treatment of multiple sclerosis. Neurotherapeutics. 2007 Oct; 4(4):647-53. Weber MS, Hohlfeld R, Zamvil SS. PMID: 17920545; PMCID: PMC7479674.
      View in: PubMed   Mentions: 43     Fields:    Translation:HumansCells
    155. Statins--treatment option for central nervous system autoimmune disease? Neurotherapeutics. 2007 Oct; 4(4):693-700. Weber MS, Steinman L, Zamvil SS. PMID: 17920550; PMCID: PMC7479672.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansAnimals
    156. Spotlight on statins. Int MS J. 2007 Sep; 14(3):93-7. Weber MS, Stuve O, Neuhaus O, Hartung HP, Zamvil SS. PMID: 18028833.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    157. Type II monocytes modulate T cell-mediated central nervous system autoimmune disease. Nat Med. 2007 Aug; 13(8):935-43. Weber MS, Prod'homme T, Youssef S, Dunn SE, Rundle CD, Lee L, Patarroyo JC, Stüve O, Sobel RA, Steinman L, Zamvil SS. PMID: 17676050.
      View in: PubMed   Mentions: 199     Fields:    Translation:AnimalsCells
    158. Combination therapies for multiple sclerosis: scientific rationale, clinical trials, and clinical practice. Curr Opin Neurol. 2007 Jun; 20(3):281-5. Costello F, Stüve O, Weber MS, Zamvil SS, Frohman E. PMID: 17495621.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansAnimals
    159. T effectors outfox T regulators in autoimmunity. Nat Med. 2007 Apr; 13(4):411-3. Prod'homme T, Weber MS, Zamvil SS. PMID: 17415374.
      View in: PubMed   Mentions: 4     Fields:    Translation:AnimalsCells
    160. Inhibition of naive Th1 CD4+ T cells by glatiramer acetate in multiple sclerosis. J Neuroimmunol. 2007 Apr; 185(1-2):123-9. Kantengwa S, Weber MS, Juillard C, Benkhoucha M, Fellay B, Zamvil SS, Gougeon ML, Chofflon M, Lalive PH. PMID: 17306890.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    161. Simvastatin regulates oligodendroglial process dynamics and survival. Glia. 2007 Jan 15; 55(2):130-43. Miron VE, Rajasekharan S, Jarjour AA, Zamvil SS, Kennedy TE, Antel JP. PMID: 17078030.
      View in: PubMed   Mentions: 35     Fields:    Translation:HumansAnimalsCells
    162. Statins in the treatment of central nervous system autoimmune disease. J Neuroimmunol. 2006 Sep; 178(1-2):140-8. Weber MS, Youssef S, Dunn SE, Prod'homme T, Neuhaus O, Stuve O, Greenwood J, Steinman L, Zamvil SS. PMID: 16860400.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansAnimalsCells
    163. How to successfully apply animal studies in experimental allergic encephalomyelitis to research on multiple sclerosis. Ann Neurol. 2006 Jul; 60(1):12-21. Steinman L, Zamvil SS. PMID: 16802293.
      View in: PubMed   Mentions: 193     Fields:    Translation:HumansAnimals
    164. Statin therapy and autoimmune disease: from protein prenylation to immunomodulation. Nat Rev Immunol. 2006 May; 6(5):358-70. Greenwood J, Steinman L, Zamvil SS. PMID: 16639429; PMCID: PMC3842637.
      View in: PubMed   Mentions: 246     Fields:    Translation:HumansAnimalsCells
    165. Immunomodulatory synergy by combination of atorvastatin and glatiramer acetate in treatment of CNS autoimmunity. J Clin Invest. 2006 Apr; 116(4):1037-44. Stüve O, Youssef S, Weber MS, Nessler S, von Büdingen HC, Hemmer B, Prod'homme T, Sobel RA, Steinman L, Zamvil SS. PMID: 16543951; PMCID: PMC1401481.
      View in: PubMed   Mentions: 54     Fields:    Translation:AnimalsCells
    166. A neuropeptide in immune-mediated inflammation, Y? Trends Immunol. 2006 Apr; 27(4):164-7. Prod'homme T, Weber MS, Steinman L, Zamvil SS. PMID: 16530483.
      View in: PubMed   Mentions: 21     Fields:    Translation:AnimalsCells
    167. Isoprenoids determine Th1/Th2 fate in pathogenic T cells, providing a mechanism of modulation of autoimmunity by atorvastatin. J Exp Med. 2006 Feb 20; 203(2):401-12. Dunn SE, Youssef S, Goldstein MJ, Prod'homme T, Weber MS, Zamvil SS, Steinman L. PMID: 16476765; PMCID: PMC2118212.
      View in: PubMed   Mentions: 90     Fields:    Translation:AnimalsCells
    168. Drug Insight: using statins to treat neuroinflammatory disease. Nat Clin Pract Neurol. 2005 Dec; 1(2):106-12. Weber MS, Prod'homme T, Steinman L, Zamvil SS. PMID: 16932506.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansAnimalsCells
    169. Therapeutic considerations for disease progression in multiple sclerosis: evidence, experience, and future expectations. Arch Neurol. 2005 Oct; 62(10):1519-30. Frohman EM, Stüve O, Havrdova E, Corboy J, Achiron A, Zivadinov R, Sorensen PS, Phillips JT, Weinshenker B, Hawker K, Hartung HP, Steinman L, Zamvil S, Cree BA, Hauser S, Weiner H, Racke MK, Filippi M. PMID: 16216934.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    170. Virtues and pitfalls of EAE for the development of therapies for multiple sclerosis. Trends Immunol. 2005 Nov; 26(11):565-71. Steinman L, Zamvil SS. PMID: 16153891.
      View in: PubMed   Mentions: 100     Fields:    Translation:Animals
    171. [Statins for treatment of CNS diseases. Status report from research and clinical practice]. Nervenarzt. 2005 Apr; 76(4):426-37. Menge T, von Büdingen HC, Zamvil SS, Hartung HP, Kieseier BC, Stüve O. PMID: 15448914.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    172. Evaluation of HMG-CoA reductase inhibitors for multiple sclerosis: opportunities and obstacles. CNS Drugs. 2005; 19(10):833-41. Neuhaus O, Stüve O, Zamvil SS, Hartung HP. PMID: 16185093.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimals
    173. Neutralizing antibodies to disease-modifying agents in the treatment of multiple sclerosis. Neurology. 2004 Dec 14; 63(11 Suppl 5):S42-9. Vartanian TK, Zamvil SS, Fox E, Sorensen PS. PMID: 15596736.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    174. Are statins a treatment option for multiple sclerosis? Lancet Neurol. 2004 Jun; 3(6):369-71. Neuhaus O, Stüve O, Zamvil SS, Hartung HP. PMID: 15157852.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    175. Mitoxantrone as a potential therapy for primary progressive multiple sclerosis. Mult Scler. 2004 Jun; 10 Suppl 1:S58-61. Stüve O, Kita M, Pelletier D, Fox RJ, Stone J, Goodkin DE, Zamvil SS. PMID: 15218811.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    176. Statins as potential therapeutic agents in multiple sclerosis. Curr Neurol Neurosci Rep. 2004 May; 4(3):237-44. Stüve O, Prod'homme T, Youssef S, Dunn S, Neuhaus O, Weber M, Hartung HP, Steinman L, Zamvil SS. PMID: 15102350.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    177. The potential therapeutic role of statins in central nervous system autoimmune disorders. Cell Mol Life Sci. 2003 Nov; 60(11):2483-91. Stüve O, Youssef S, Dunn S, Slavin AJ, Steinman L, Zamvil SS. PMID: 14625690.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimalsCells
    178. Statins and their potential targets in multiple sclerosis therapy. Expert Opin Ther Targets. 2003 Oct; 7(5):613-22. Stüve O, Prod'homme T, Slavin A, Youssef S, Dunn S, Steinman L, Zamvil SS. PMID: 14498824.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansAnimalsCells
    179. Efficient technique for immortalization of murine microglial cells relevant for studies in murine models of multiple sclerosis. J Neurosci Methods. 2003 Sep 30; 128(1-2):33-43. Olson JK, Zamvil SS, Miller SD. PMID: 12948546.
      View in: PubMed   Mentions: 2     Fields:    Translation:AnimalsCells
    180. MRI lesion volume heterogeneity in primary progressive MS in relation with axonal damage and brain atrophy. J Neurol Neurosurg Psychiatry. 2003 Jul; 74(7):950-2. Pelletier D, Nelson SJ, Oh J, Antel JP, Kita M, Zamvil SS, Goodkin DE. PMID: 12810788; PMCID: PMC1738553.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    181. Diverse targets for intervention during inflammatory and neurodegenerative phases of multiple sclerosis. Neuron. 2003 Jun 05; 38(5):685-8. Zamvil SS, Steinman L. PMID: 12797954.
      View in: PubMed   Mentions: 47     Fields:    Translation:HumansAnimalsCells
    182. Transcriptional analysis of targets in multiple sclerosis. Nat Rev Immunol. 2003 Jun; 3(6):483-92. Steinman L, Zamvil S. PMID: 12776208.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    183. Statins as potential therapeutic agents in neuroinflammatory disorders. Curr Opin Neurol. 2003 Jun; 16(3):393-401. Stüve O, Youssef S, Steinman L, Zamvil SS. PMID: 12858078.
      View in: PubMed   Mentions: 41     Fields:    Translation:HumansAnimalsCells
    184. The role of the MHC class II transactivator in class II expression and antigen presentation by astrocytes and in susceptibility to central nervous system autoimmune disease. J Immunol. 2002 Dec 15; 169(12):6720-32. Stüve O, Youssef S, Slavin AJ, King CL, Patarroyo JC, Hirschberg DL, Brickey WJ, Soos JM, Piskurich JF, Chapman HA, Zamvil SS. PMID: 12471103.
      View in: PubMed   Mentions: 36     Fields:    Translation:AnimalsCells
    185. Approved and future pharmacotherapy for multiple sclerosis. Neurologist. 2002 Sep; 8(5):290-301. Stüve O, Cree BC, von Büdingen HC, Yousef S, Bowen JD, Genain CP, Hauser SL, Steinman L, Zamvil SS. PMID: 12803676.
      View in: PubMed   Mentions: 4     Fields:    
    186. Single nucleotide polymorphisms in MHC2TA, the gene encoding the MHC class II transactivator (CIITA). Genes Immun. 2002 Feb; 3(1):34-7. Patarroyo JC, Stuve O, Piskurich JF, Hauser SL, Oksenberg JR, Zamvil SS. PMID: 11857059.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    187. Malignant glioma cells use MHC class II transactivator (CIITA) promoters III and IV to direct IFN-gamma-inducible CIITA expression and can function as nonprofessional antigen presenting cells in endocytic processing and CD4(+) T-cell activation. Glia. 2001 Dec; 36(3):391-405. Soos JM, Krieger JI, Stüve O, King CL, Patarroyo JC, Aldape K, Wosik K, Slavin AJ, Nelson PA, Antel JP, Zamvil SS. PMID: 11746775.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCells
    188. Requirement for endocytic antigen processing and influence of invariant chain and H-2M deficiencies in CNS autoimmunity. J Clin Invest. 2001 Oct; 108(8):1133-9. Slavin AJ, Soos JM, Stuve O, Patarroyo JC, Weiner HL, Fontana A, Bikoff EK, Zamvil SS. PMID: 11602620; PMCID: PMC209531.
      View in: PubMed   Mentions: 38     Fields:    Translation:AnimalsCells
    189. Specific immunotherapy: one size does not fit all. Nat Med. 2000 Oct; 6(10):1098-100. Genain CP, Zamvil SS. PMID: 11017135.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    190. Pathogenesis, diagnosis, and treatment of acute disseminated encephalomyelitis. Curr Opin Neurol. 1999 Aug; 12(4):395-401. Stüve O, Zamvil SS. PMID: 10555827.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    191. Differential expression of B7 co-stimulatory molecules by astrocytes correlates with T cell activation and cytokine production. Int Immunol. 1999 Jul; 11(7):1169-79. Soos JM, Ashley TA, Morrow J, Patarroyo JC, Szente BE, Zamvil SS. PMID: 10383950.
      View in: PubMed   Mentions: 17     Fields:    Translation:AnimalsCells
    192. Highlights from the Fifth International Congress of the International Society of Neuroimmunology. J Neuroimmunol. 1999 Jun 01; 97(1-2):4-8. Freedman MS, Ransohoff R, Talbot PJ, Zamvil SS. PMID: 10408977.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    193. Astrocytes express elements of the class II endocytic pathway and process central nervous system autoantigen for presentation to encephalitogenic T cells. J Immunol. 1998 Dec 01; 161(11):5959-66. Soos JM, Morrow J, Ashley TA, Szente BE, Bikoff EK, Zamvil SS. PMID: 9834077.
      View in: PubMed   Mentions: 38     Fields:    Translation:HumansAnimalsCells
    194. Pathogenesis and treatment of central nervous system demyelinating disease. Rev Neurol (Paris). 1998 Sep; 154(8-9):573-5. Zamvil SS, Soos JM, Weiner HL. PMID: 9809371.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    195. Prior exposure to superantigen can inhibit or exacerbate autoimmune encephalomyelitis: T-cell repertoire engaged by the autoantigen determines clinical outcome. J Neuroimmunol. 1996 Dec; 71(1-2):3-10. Das MR, Cohen A, Zamvil SS, Offner H, Kuchroo VK. PMID: 8982096.
      View in: PubMed   Mentions: 1     Fields:    Translation:AnimalsCells
    196. Effect of oral beta interferon on subsequent immune responsiveness. Ann N Y Acad Sci. 1996 Feb 13; 778:145-55. Nelson PA, Akselband Y, Dearborn SM, Al-Sabbagh A, Tian ZJ, Gonnella PA, Zamvil SS, Chen Y, Weiner HL. PMID: 8610968.
      View in: PubMed   Mentions: 4     Fields:    Translation:AnimalsCells
    197. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell. 1995 Mar 10; 80(5):707-18. Kuchroo VK, Das MP, Brown JA, Ranger AM, Zamvil SS, Sobel RA, Weiner HL, Nabavi N, Glimcher LH. PMID: 7534215.
      View in: PubMed   Mentions: 334     Fields:    Translation:AnimalsCellsPHPublic Health
    198. Reciprocal expression of co-stimulatory molecules, B7-1 and B7-2, on murine T cells following activation. Eur J Immunol. 1995 Jan; 25(1):207-11. Prabhu Das MR, Zamvil SS, Borriello F, Weiner HL, Sharpe AH, Kuchroo VK. PMID: 7531145.
      View in: PubMed   Mentions: 18     Fields:    Translation:AnimalsCells
    199. T cell receptor (TCR) usage determines disease susceptibility in experimental autoimmune encephalomyelitis: studies with TCR V beta 8.2 transgenic mice. J Exp Med. 1994 May 01; 179(5):1659-64. Kuchroo VK, Collins M, al-Sabbagh A, Sobel RA, Whitters MJ, Zamvil SS, Dorf ME, Hafler DA, Seidman JG, Weiner HL, et al. PMID: 8163944; PMCID: PMC2191471.
      View in: PubMed   Mentions: 8     Fields:    Translation:AnimalsCells
    200. 'Lupus-prone' mice are susceptible to organ-specific autoimmune disease, experimental allergic encephalomyelitis. Pathobiology. 1994; 62(3):113-9. Zamvil SS, al-Sabbagh A, Nelson PA, Kaul D, Charles MS, Mitchell DJ, Steinman L, Weiner HL, Kuchroo VK. PMID: 7524528.
      View in: PubMed   Mentions: 1     Fields:    Translation:AnimalsCells
    201. Localization of an encephalitogenic epitope for the SJL mouse in the N-terminal region of myelin basic protein. J Neuroimmunol. 1990 Mar; 26(3):239-43. Fritz RB, Skeen MJ, Chou CH, Zamvil SS. PMID: 1689745.
      View in: PubMed   Mentions: 3     Fields:    Translation:AnimalsCells
    202. Lymphotoxin and tumor necrosis factor-alpha production by myelin basic protein-specific T cell clones correlates with encephalitogenicity. Int Immunol. 1990; 2(6):539-44. Powell MB, Mitchell D, Lederman J, Buckmeier J, Zamvil SS, Graham M, Ruddle NH, Steinman L. PMID: 1707660.
      View in: PubMed   Mentions: 50     Fields:    Translation:AnimalsCells
    203. The T lymphocyte in experimental allergic encephalomyelitis. Annu Rev Immunol. 1990; 8:579-621. Zamvil SS, Steinman L. PMID: 2188675.
      View in: PubMed   Mentions: 275     Fields:    Translation:HumansAnimalsCells
    204. Prevention of experimental encephalomyelitis with peptides that block interaction of T cells with major histocompatibility complex proteins. Proc Natl Acad Sci U S A. 1989 Dec; 86(23):9470-4. Sakai K, Zamvil SS, Mitchell DJ, Hodgkinson S, Rothbard JB, Steinman L. PMID: 2480602; PMCID: PMC298518.
      View in: PubMed   Mentions: 30     Fields:    Translation:AnimalsCells
    205. Polymorphic residues on the I-A beta chain modulate the stimulation of T cell clones specific for the N-terminal peptide of the autoantigen myelin basic protein. J Immunol. 1989 Oct 01; 143(7):2083-93. Davis CB, Mitchell DJ, Wraith DC, Todd JA, Zamvil SS, McDevitt HO, Steinman L, Jones PP. PMID: 2476496.
      View in: PubMed   Mentions: 9     Fields:    Translation:AnimalsCells
    206. Autoimmune demyelinating disease. West J Med. 1989 Mar; 150(3):335-6. Zamvil SS, Steinman L. PMID: 18750550; PMCID: PMC1026460.
      View in: PubMed   Mentions:    Fields:    
    207. Involvement of distinct murine T-cell receptors in the autoimmune encephalitogenic response to nested epitopes of myelin basic protein. Proc Natl Acad Sci U S A. 1988 Nov; 85(22):8608-12. Sakai K, Sinha AA, Mitchell DJ, Zamvil SS, Rothbard JB, McDevitt HO, Steinman L. PMID: 2460872; PMCID: PMC282508.
      View in: PubMed   Mentions: 32     Fields:    Translation:AnimalsCells
    208. Multiple discrete encephalitogenic epitopes of the autoantigen myelin basic protein include a determinant for I-E class II-restricted T cells. J Exp Med. 1988 Sep 01; 168(3):1181-6. Zamvil SS, Mitchell DJ, Powell MB, Sakai K, Rothbard JB, Steinman L. PMID: 2459291; PMCID: PMC2189022.
      View in: PubMed   Mentions: 22     Fields:    Translation:AnimalsCells
    209. Characterization of a major encephalitogenic T cell epitope in SJL/J mice with synthetic oligopeptides of myelin basic protein. J Neuroimmunol. 1988 Aug; 19(1-2):21-32. Sakai K, Zamvil SS, Mitchell DJ, Lim M, Rothbard JB, Steinman L. PMID: 2456304.
      View in: PubMed   Mentions: 35     Fields:    Translation:AnimalsCells
    210. Limited heterogeneity of T cell receptors from lymphocytes mediating autoimmune encephalomyelitis allows specific immune intervention. Cell. 1988 Jul 15; 54(2):263-73. Acha-Orbea H, Mitchell DJ, Timmermann L, Wraith DC, Tausch GS, Waldor MK, Zamvil SS, McDevitt HO, Steinman L. PMID: 2455603.
      View in: PubMed   Mentions: 225     Fields:    Translation:AnimalsCells
    211. Predominant expression of a T cell receptor V beta gene subfamily in autoimmune encephalomyelitis. J Exp Med. 1988 May 01; 167(5):1586-96. Zamvil SS, Mitchell DJ, Lee NE, Moore AC, Waldor MK, Sakai K, Rothbard JB, McDevitt HO, Steinman L, Acha-Orbea H. PMID: 2452856; PMCID: PMC2188936.
      View in: PubMed   Mentions: 45     Fields:    Translation:AnimalsCells
    212. Comparison of antigen specificity, class II major histocompatibility complex restriction, and in vivo behavior of myelin basic protein-specific T cell lines and clones derived from (BALB/c x SJL/J) mice. J Immunol. 1987 Sep 15; 139(6):1834-9. Trotter J, Zamvil SS, Steinman L. PMID: 2442257.
      View in: PubMed   Mentions: 3     Fields:    Translation:AnimalsCells
    213. T cell specificity for class II (I-A) and the encephalitogenic N-terminal epitope of the autoantigen myelin basic protein. J Immunol. 1987 Aug 15; 139(4):1075-9. Zamvil SS, Mitchell DJ, Moore AC, Schwarz AJ, Stiefel W, Nelson PA, Rothbard JB, Steinman L. PMID: 2440944.
      View in: PubMed   Mentions: 11     Fields:    Translation:AnimalsCells
    214. T-cell epitope of the autoantigen myelin basic protein that induces encephalomyelitis. Nature. 1986 Nov 20-26; 324(6094):258-60. Zamvil SS, Mitchell DJ, Moore AC, Kitamura K, Steinman L, Rothbard JB. PMID: 2431317.
      View in: PubMed   Mentions: 136     Fields:    Translation:AnimalsCells
    215. Therapy of autoimmune diseases with antibody to immune response gene products or to T-cell surface markers. Ann N Y Acad Sci. 1986; 475:274-84. Steinman L, Waldor MK, Zamvil SS, Lim M, Herzenberg L, Herzenberg L, McDevitt HO, Mitchell D, Sriram S. PMID: 3098154.
      View in: PubMed   Mentions: 4     Fields:    Translation:Animals
    216. Encephalitogenic T cell clones specific for myelin basic protein. An unusual bias in antigen recognition. J Exp Med. 1985 Dec 01; 162(6):2107-24. Zamvil SS, Nelson PA, Mitchell DJ, Knobler RL, Fritz RB, Steinman L. PMID: 2415664; PMCID: PMC2187974.
      View in: PubMed   Mentions: 41     Fields:    Translation:AnimalsCells
    217. T-cell clones specific for myelin basic protein induce chronic relapsing paralysis and demyelination. Nature. 1985 Sep 26-Oct 2; 317(6035):355-8. Zamvil S, Nelson P, Trotter J, Mitchell D, Knobler R, Fritz R, Steinman L. PMID: 2413363.
      View in: PubMed   Mentions: 144     Fields:    Translation:AnimalsCells
    218. Prevention of experimental allergic encephalitis with in vivo administration of anti I-A antibody. Decreased accumulation of radiolabelled lymph node cells in the central nervous system. J Neuroimmunol. 1983 Aug; 5(1):91-7. Steinman L, Solomon D, Lim M, Zamvil S, Sriram S. PMID: 6603474.
      View in: PubMed   Mentions: 9     Fields:    Translation:AnimalsPHPublic Health
    219. Murine model for pertussis vaccine encephalopathy: linkage to H-2. Nature. 1982 Oct 21; 299(5885):738-40. Steinman L, Sriram S, Adelman NE, Zamvil S, McDevitt HO, Urich H. PMID: 7121603.
      View in: PubMed   Mentions: 6     Fields:    Translation:Animals
    220. In vitro cellular respiration at elevated temperatures in developing rat cerebral cortex. Brain Res. 1982 Aug; 256(4):401-5. Holtzman D, Nguyen H, Zamvil S, Olson J. PMID: 7127147.
      View in: PubMed   Mentions:    Fields:    Translation:Animals
    221. Maturation of potassium-stimulated respiration in rat cerebral cortical slices. J Neurochem. 1982 Jul; 39(1):274-6. Holtzman D, Olson J, Zamvil S, Nguyen H. PMID: 7086416.
      View in: PubMed   Mentions: 4     Fields:    Translation:Animals
    222. Response to the RIF-1 tumor in vitro and in C3H/Km mice to X-radiation (cell survival, regrowth delay, and tumor control), chemotherapeutic agents, and activated macrophages. J Natl Cancer Inst. 1980 Mar; 64(3):605-11. Brown JM, Twentyman PR, Zamvil SS. PMID: 6928245.
      View in: PubMed   Mentions: 10     Fields:    Translation:AnimalsCells
    With one click, see people who:

    Mentor Faculty

    Run Clinical Trials

    Work in Global Health Equity

    Offer Student Projects

    See more options in the Advanced Search tab

    Scott's Networks
    Concepts (566)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (91)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSF Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).

    We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use. This site is running Profiles RNS version UCSF-v3.1.0-3-g1ef1264b on PROFILES-PWEB04.

    Copyright © The Regents of the University of California.